ABSTRACT Bronchoalveolar lavage was used to sample inflammatory cells from the lungs of 51 patients with cryptogenic fibrosing alveolitis (CFA) (24 smokers, 12 ex-smokers, and 15 non-smokers). The smokers with CFA have been compared with 15 smoking control subjects in whom there was no radiographic abnormality or clinical evidence of chronic bronchitis. Significantly lower volumes of lavage fluid were recovered from the smokers with CFA (p < 0 001) and the fluid contained lower percentages of macrophages (p < 0Ol), reflecting increased percentages of eosinophils (p < 000l) and neutrophils (p < 0 01). Similar changes were seen in the ex-smokers and non-smokers. There was also an increase in the percentages of lymphocytes when the whole group of CFA patients was compared with the control subjects (p < 0 05). No significant differences were found when patients with "lone" CFA were compared with those having associated systemic disease. The only feature distinguishing smokers from non-smokers with CFA was the presence of pigmented cytoplasmic inclusions in the macrophages from the smokers (p < 0 001). However, there were lower numbers of pigmented macrophages in the smoking CFA patients by comparison with the control subjects suggesting either a change in phagocytic capacity or turnover rate in this disease. Profiles of differential cell counts in individual patients showed that increases of eosinophils over 30% or neutrophils over 40% or both with lymphocyte counts of less than 11 0% related to a poor clinical response to corticosteroids, but lymphocyte percentages greater than 11°/ , related to improvement (p < 0 05).
differential cell counts in individual patients showed that increases of eosinophils over 30% or neutrophils over 40% or both with lymphocyte counts of less than 11 0% related to a poor clinical response to corticosteroids, but lymphocyte percentages greater than 11°/ , related to improvement (p < 0 05).
Earlier studies have shown that the cell populations of bronchoalveolar lavage fluids in normal volunteers are mainly alveolar macrophages with small numbers of lymphocytes.1 2 The influence of smoking in normal volunteers has demonstrated significantly higher total cell yields with increased percentages of macrophages and decreased lymphocytes.' 3 Thus the influence of smoking must be taken into account in any clinical study.
Lung lavage samples obtained from patients with interstitial pulmonary fibrosis (IPF) have been compared with those from normal healthy volunteers and control patients without peripheral lung disease. 4 5 In IPF percentages of alveolar macrophages were reduced reflecting an increase in neutrophils and eosinophils. Smoking did not influence these findings but neutrophil percentages were lower in the patients receiving corticosteroid treatment.
In the present study we consider patients with cryptogenic fibrosing alveolitis (CFA) in whom the clinical features are very similar to cases in other reports described as interstitial pulmonary fibrosis. We extend previous observations and compare patients with and without associated systemic disorders. We also relate differential lavage cell counts to the progression rate of disease and the clinical response to corticosteroid treatment.
Methods

PATIENTS WITH CRYPTOGENIC
FIBROSING ALVEOLITIS (CFA) We studied 51 patients with clinical, radiological, and physiological evidence of cryptogenic fibrosing alveolitis. The diagnostic criteria were breathlessness, widespread crackles especially over the lower lobes of the lungs, widespread shadowing on the chest radiograph, and a restrictive ventila-Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis tory defect without airways obstruction. Other known causes of chronic widespread lung shadowing such as inhaled inorganic or organic dusts or sarcoidosis were reasonably excluded. Histological confirmation of the diagnosis was available in 30 cases. Thirty-six of 51 patients had only the lung disorder, and included 29 men and seven women (mean age 56 years ±9 SD, range 33-79 yr). Twenty-six patients were untreated at the time of lung lavage but 10 were receiving treatment with immunosuppressive or anti-inflammatory drugs-prednisone in nine and prednisone and penicillamine in one. Nineteen were smokers, 10 ex-smokers, and seven nonsmokers.
The remaining 15 of the 51 patients had the lung disorder in association with connective tissue disorders of other systems, and included 10 men and five women (mean age 47 years + 11 SD, range 29-64 yr). Five were untreated at the time of lung lavage and included two with associated systemic sclerosis, one with systemic lupus erythematosus, one with dermatomyositis, and one with thyroiditis. The remaining 10 patients were receiving treatment (four prednisone, two prednisone and penicillamine, one prednisone together with cyclophosphamide, cyproheptidine, and colchicine, two cyclophosphamide, cyproheptidine, and colchicine, and one prednisone and azathioprine). Three of these patients had associated rheumatoid arthritis (RA), four systemic sclerosis, two dermatomyositis, and one SLE, Raynaud's and Sjogren's syndrome. Five of the 15 patients with associated disorders were smokers, two ex-smokers, and eight non-smokers.
Rate of natural progression was assessed for the 31 untreated patients by questioning them at the time of admission for lavage about their breathlessness over the previous six to 12 months. In 16 cases it was also possible to assess post-lavage progression from clinical, radiographic, and physiological follow-up over a further year when they remained untreated.
Response to treatment with prednisone or other immunosuppressive and anti-inflammatory drugs was assessed from clinical, radiographic, and physiological post-treatment follow-up over a period of at least 12 months to determine both initial (one month) and maintained (12 The method used and its acceptability to patients are described in detail elsewhere." In brief, lavage was performed after premedication with atropine and omnopon under local anaesthetic using lignocaine through an Olympus fibreoptic bronchoscope, and all patients received supplementary oxygen. The tip of the bronchoscope was wedged into the lateral basal segment of the right lower lobe and 60 ml aliquots of sterile normal saline, buffered to pH 7'0 with 8-4% sodium bicarbonate were introduced and aspirated. The mean fluid volume introduced was 397 ml + 76 SD (range 120-540 ml), the mean volume of fluid retrieved was 114 ml ±27 SD (range 60-150 ml), and the mean percentage fluid recovery was 29% +8 SD (range 10-42% 
Results
LAVAGE FLUID RECOVERY
There were lower percentages of fluid recovered from patients with "lone" CFA and similarly from those with associated disorders than from the smoking control subjects (pS0 001; fig 2) . The mean percentage fluid recovery for the total patients with lone and associated systemic disorders was 27% (range 10-43%) compared with a mean of 36% (range 26-54%) for the smoking control subjects. Smoking and treatment within the CFA groups is also indicated in fig 2 and similar results for smokers, ex-smokers, and nonsmokers and for treated and untreated patients were confirmed in the statistical tests. 
LAVAGE CELLS YIELDS
The mean volume of fluid recovered from smoking control subjects was 120 ml (range 65-150 ml) containing a mean absolute total number of 61-59 x 106 nucleated cells (range 7-7-152-6 x 106). The mean volume recovered from patients with lone CFA was 113 ml (range 60-160 ml) containing a mean of 80 8 x 106 cells (range 3-3-492-6 x 106), and from patients with CFA having associated connective tissue disorders was 113 ml (range 50-150 ml) with a mean of 36-42 x 106 cells (range 6-4-102 x 106). The variation in cell yields was independent of the variation in fluid recovery volumes (r= 0 28, NS).
There was a highly significant correlation between absolute total cell yields and cell yields per ml of lavage fluid recovered (r=0-98, p<0-001), and for comparative purposes yields have been expressed as total numbers of cells per ml. The results are shown in fig 3 . Cell yields were lower in CFA patients having associated disorders (mean 0-3 x 106, range 0 01-1 02 x 106) than in the smoking control subjects (mean 0-53 X 106, range 0-06-1-27 x 106) (p<0-05) but this reflected a significant trend towards lower cell yields in the non-smoking patients (p=0 025). However, a general trend towards lower cell yields in non-smokers compared with smokers with CFA did not reach statistical significance. Cell yields in patients with lone CFA resembled those in the smoking control subjects, although two individuals were distinguished by inexplicably high cell yields (fig 3) . There was no significant effect of treatment on cell yields within the CFA group.
DIFFERENTIAL COUNTS OF LAVAGE CELLS
Macrophages Differential count percentages of "macrophages" are shown in fig 4a. The counts include the range of "macrophage" appearances, but in every case the great majority were large mononuclear cells with clear or foamy cytoplasm. "Macrophage" counts were significantly lower in lone CFA (mean 71 %, range 19-96%) and in CFA with associated disorders (mean 65%, range 23-92%), than in the smoking control subjects (mean 87%, range 41-99%), p<0 01 and p<0 001 respectively). The decrease was apparent irrespective of smoking or treatment. Within the CFA group smokers had slightly higher macrophage counts than non-smokers as has been reported for normal volunteers,' 3 but unlike the normal situation this did not reach significance. Lymphocytes Differential count percentages of fig 4b. The majority were small or large lymphocytes and variants with marked nuclear indentation were extremely rare. A trend towards higher lymphocyte counts in patients with CFA compared with smoking control subjects only reached significance for the total CFA patients (p<005 for lone CFA; p=001 for CFA with associated disorders) not for the smokers alone. The mean for the total with lone CFA was 6% (range 0 2-30%) and for those with associated disorders was 12% (range 0-65%). The mean for the smoking control subjects was 3% (range 04-11%) and for the total CFA smokers 7% (range 0-30%). Four CFA smokers had counts above the 11% upper limit for the smoking control subjects. Lymphocyte counts were slightly higher for the total CFA non-smokers (mean 14%, range 1-65%), but within the CFA group the difference between non-smokers and smokers was not significant, and three of the 15 non-smoking patients had lymphocyte counts higher than the 20% upper limit reported for normal non-smokers.' 4 5 Counts were not significantly different in patients on and off treatment. Neutrophils Differential count percentages of neutrophils are shown in fig Sa. The majority of smoking control subjects had neutrophil counts less than 4% although three had higher counts. The mean neutrophil count for the controls was 6% (range 0-2-36%). By comparison, the counts for CFA were significantly increased irrespective of smoking or associated disease. The mean count for the total with lone CFA was 13% (range 0-43%) (p<0-001 compared with control subjects). The mean for the total with CFA and associated disorders was 13% (range 0-6-68%) (p<001 compared with control subjects). Of the patients with associated disorders, the two with the highest neutrophil counts (36% and 68%) had dermatomyositis. Neutrophil counts for treated and untreated patients with CFA did not differ significantly. group.bmj.com on April 15, 2017 -Published by http://thorax.bmj.com/ Downloaded from P L Haslam et al with CFA. The mean for -the total patients with lone CFA was 6-2%, range 0-31.5% (p<0-001 compared with control subjects) and the increase was significant irrespective of the smoking habit. The mean for the total patients with associated disorders was 5 9% (range 0-27 6%) (p<0-01 compared with control subjects) although this was only confirmed for the smokers. However, there was no significant influence of smoking in either CFA group. Eosinophil counts were significantly lower in treated (mean 21 %, range 0 to 86%) than in untreated (mean 77%, range 0-31-5%) patients with lone CFA (p<0025) but no significant effect of treatment was demonstrated in patients with associated disorders.
PERIPHERAL BLOOD EOSINOPHIL COUNTS IN CFA
Only four (8%) of the total 51 CFA patients in this study, including only two (9%) of the 23 with lavage eosinophils increased above 3% had a peripheral blood eosinophil count greater than 0-4/nl at the time of lavage. The peripheral blood white cell counts were normal in these four patients.
DENSELY PIGMENTED MACROPHAGE CYTOPLASMIC INCLUSIONS
Numerous densely pigmented irregular inclusions were clearly visible in the cytoplasm of variable numbers of "macrophages" from smokers and ex-smokers, but this feature was very rare in non-smokers (fig 6) . This correlation of increased for eosinophils by whole numbers). In the case of neutrophils, because of the markedly skew distribution of counts in our control subjects from three high values, levels exceeding 4% were accepted as increased; this value included all our other control subjects and is in line with the upper limit of neutrophils in normal volunteers.' 3 (In the absence of non-smoking control subjects, "Increase" does not necessarily imply abnormality). Forty-seven (92%) of the total 51 CFA patients had an increase in at least one inflammatory cell type. The most common patterns of increase were combined increases in neutrophils and eosinophils (37%) or increases in neutrophils alone (31%). Combined eosinophil-neutrophil increases were, however, notably the more common in patients with lone CFA and in patients untreated at lavage, while neutrophil increases only were notably more common in patients with associated extrapulmonary connective tissue disorders and in patients on treatment at lavage. Lymphocyte counts higher than 11% occurred in nine (18%) of the total 51 patients, combined with neutrophil increases in four and with eosinophil as well as neutrophil increases in just two cases.
RELATIONSHIP OF DIFFERENTIAL LAVAGE CELL COUNTS TO RESPONSE TO PREDNISONE AND OTHER IMMUNOSUPPRESSIVE AND ANTI-INFLAMMATORY DRUGS IN CFA
The value of differential lavage cell counting in predicting maintained response to treatment was explored in 14 patients untreated at lavage but subsequently treated, and in 18 patients on treatment at the time of lavage. Full clinical, radiographic and physiological post-treatment followup was available for these patients to allow assessment of both initial and maintained response. The relationship of the levels of lavage cell counts to maintained response and drug regimens at the end of the follow-up period in these patients is shown in fig 8. Patients who responded to prednisone (fig 8a) had significantly decreased levels of lavage eosinophils compared with non-responders (p=0 036). The trend towards higher levels of lymphocytes in the responders did not achieve statistical significance. The neutrophil levels were not by themselves useful in distinguishing responders from nonresponders. The profiles of lavage cell increases in individual patients (table 2) were important in showing a significant correlation of prednisone response with lavage lymphocyte counts higher than 11% irrespective of associated increases in neutrophils and eosinophils (six of eight responders), but of failure to respond with combined increases in neutrophils and eosinophils or increases in neutrophils without increases in lymphocytes (eight of nine non-responders) (p<005).
Patients who had failed to respond to prednisone or where prednisone was contraindicated and who were treated with cyclophosphamide, in some cases with various combinations of other drugs, are also considered in fig 8b and in table 2 . Response to these drugs occurred in eight of the 15 patients and none had increased lavage lymphocyte counts (the patients with lymphocyte counts higher than 11 % having been selected into prednisone responsive group). The lavage cell profiles showed that response to these drugs could be obtained in patients with combined increases in neutrophils and eosinophils, or increases in (fig 8b) in the responders compared with the non-responders (p= 0-014). Response was achieved with the introduction of cyclophosphamide in six of the eight responders.
Discussion
The results of this study have confirmed the lung lavage findings of Reynolds et al4 in CFA in several respects. Significantly lower lavage fluid recoveries have been confirmed in CFA by comparison with smoking control subjects without interstitial lung disease, and it has also been confirmed that lavage cell yields in smokers and non-smokers with CFA are similar to those in smoking control subjects. This contrasts with Reynolds and Newball's' findings in normal healthy volunteers where lavage cell yields were three times higher in smokers than non-smokers and related to increased numbers of macrophages. These observations suggest increased lavage cell yields in non-smokers with CFA. It is, however, surprising that cell yields, and in particular macrophage yields, were not increased in smokers with CFA over smoking control subjects in view of the remarkably different histological appearance of normal and CFA lung.
Differential counting of lavage cells has, moreover, confirmed a significant smoking-independent trend towards lower percentages of macrophages in CFA compared with smoking control subjects reflecting significantly increased percentages of eosinophils and neutrophils, and our study has also demonstrated that lymphocytes are occasionally increased. As 20 and have recently been identified in lavage fluids.'7 21 Immune complexes can trigger direct release of neutrophil chemotactic factors from macrophages in vitro.'7 They may also trigger local complement activation and the activation products C3a and C5a through their chemotactic activity may attract neutrophils and eosinophils. C3a and C5a acting as anaphylatoxins may also stimulate the release of eosinophil chemotactic factor from mast cells, and the finding of histamine in lavage fluids in cases with eosinophils22 provides some support for this. Whether there are separate explanations for neutrophil increases with and without associated eosinophil increases is not known. Features we have occasionally observed in CFA lavage eosinophils which are thought to relate to longevity or activation, are cytoplasmic vacuolation, Fc receptors for rabbit IgG, and morphological alteration of the crystalloid granules. 22 These have been reported in tissue eosinophils but are very rare in normal blood eosinophils. 23 The significance of our small increases in lavage lymphocytes are difficult to interpret in view of the absence of appropriate data in agematched non-smoking control subjects. However, the interest of this small minority is that they tend to respond to corticosteroids. Both T and B lymphocytes have been demonstrated in CFA lavage fluids but in proportions similar to those in blood,24 25 and this contrasts with the predominance of T lymphocytes in lavages of sarcoidosis and hypersensitivity pneumonitis.4 5 25 Observations suggestive of local B lymphocyte stimulation in CFA are the frequent presence of immunoglobulin-containing plasma cells, sometimes together with germinal follicles, in CFA lung biopsies26 and increased IgG: albumin ratios in CFA lavage fluids compared with blood. 4 There is so far no evidence of activated P L Haslam et al T lymphocytes in CFA lungs but T cells sensitised to collagen have been detected in the blood.27 Evidence of neutral protease production from macrophages after stimulation with lymphokines28 suggests that if lymphokines are present locally in some patients this may provide another route to leucocyte chemotactic factor production.
Current studies of bronchoalveolar lavage in CFA are providing considerable information about the components of the inflammatory process. This knowledge should now be applied to devise logical approaches to new forms of treatment. 
